Similar views, in line with Morgan Stanley's 15 % correction outlook in 4th Q.
I positioned myself defensively since some time.
A few healthcare stocks with news in 4th Q are still interesting.
Biotech stocks, especially those related to COVID and mRNA hold value, IMO.
Broader market is something to stay away from, fully agree.
Valuations have to come down, growth outlook in the US has been halved, strong growth already priced in, so prices have little room to improve.
We are now 240 days on the S&P without a 5 % correction, which is highly unsustainable.
So investors would do well to position accordingly.
all IMO
ADO Charting and Technical Analysis, page-1816
-
- There are more pages in this discussion • 7,558 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
-0.002(8.33%) |
Mkt cap ! $54.31M | |||
| Open | High | Low | Value | Volume |
| 2.4¢ | 2.4¢ | 2.2¢ | $12.59K | 542.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 487271 | 2.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.3¢ | 200000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| ADO (ASX) Chart |